Gould Robert J - Insider Non-Derivative Transactions at Fulcrum Therapeutics, Inc. (FULC) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 13, 2023, Gould Robert J's relationship to Fulcrum Therapeutics, Inc. (FULC) is Director,Officer (Interim President & CEO), and currently has 499,864 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other FULC insiders.
Data Source: SEC.
Gould Robert J - Insider Non-Derivative Transactions at FULC
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jan 14, 2023 | Sell -- (Common Stock) | 6766 | 15 | 499864 |